ALLEN PARK: Open Payments
NPI 1548714181 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,660 in 64 payments from 8 companies in 2025. Trend: 2023 $1,180 · 2024 $1,584 · 2025 $1,660
Food & beverage: $1,660
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $653 |
| Neurocrine BioSciences, Inc. | 10 | $382 |
| Alkermes, Inc. | 8 | $212 |
| E.R. Squibb & Sons, L.L.C. | 8 | $180 |
| Otsuka America Pharmaceutical, Inc. | 4 | $86 |
| Axsome Therapeutics, Inc. | 3 | $69 |
| Janssen Pharmaceuticals, Inc | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
Products named: VRAYLAR, INGREZZA, ARISTADA, COBENFY, Auvelity, REXULTI, ABILIFY ASIMTUFII, INVEGA SUSTENNA.
Industry payments across NV — which companies pay providers there.
